The childhood spinal muscular atrophies (SMAs) are the most common, serious neuromuscular disorders of childhood second to Duchenne muscular dystrophy. A single locus for these disorders has been mapped by recombination events to a region of 0.7 centimorgan (range, 0.1-2.1 centimorgans) between loci D5S435 and MAPIB on chromosome 5q11.2-13.3. By using PCR amplification to screen yeast artificial chromosome (YAC) DNA pools and the PCRvectorette method to amplify YAC ends, a YAC contig was constructed across the disease gene region. Nine walk steps identified 32 YACs, including a minimum of seven overlapping YAC clones (average size, 460 kb) that span the SMA region. The contig is characterized by a collection of 30 YAC-end sequence tag sites together with seven genetic markers. The entire VAC contig spans a minimum of 3.2 Mb; the SMA locus is confined to roughly half of this region. MicrosateUlite markers generated along the YAC contig segregate with the SMA locus in al families where the flanking markers (DSS435 and MAPIB) recombine.
The childhood spinal muscular atrophies (SMAs) are a group of recessively inherited disorders characterized by degeneration of the anterior horn cells of the spinal cord and symmetrical weakness and wasting ofthe proximal voluntary muscles. For all types of SMA, diagnosis is based upon clinical examination and evidence of denervation confirmed by muscle biopsy and electromyographic results. Three broad disease categories can be defined, based upon severity ofillness, but all classes overlap one another (1) (2) (3) . SMA type I (Werdnig-Hoffmann disease; severe SMA; acute SMA) is the most severe form with onset of symptoms before birth to several months of age. These children never raise their heads or sit unattended and usually die from infection secondary to respiratory insufficiency in the first few years of life. SMA types II (intermediate) and III (Kugelberg-Welander; mild SMA) are clinically more heterogeneous with onset ranging from 3 mo to 17 yr. Together, the childhood SMAs are second to cystic fibrosis as the leading cause of childhood mortality, affecting one in 10,000 live births with a carrier frequency of 1/40 to 1/60 (4, 5) . All three forms of SMA have been genetically mapped to chromosome 5q11.2-13.3 (6) (7) (8) (9) .
To facilitate the isolation and identification of the SMAencoding gene, we physically mapped and cloned the SMA gene region. Because no DNA markers or sequence tag sites (STSs) had been mapped to the interval between flanking markers DSS435 and MAPIB (10) (11) (12) , the following strategy
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in accordance with 18 (1536 YACs) . Each of these high-density pools was subdivided into 36 "grid" pools. Sixteen "plate" pools were made from the individual 96-well plates by replicating each plate singly. Twelve "column" pools and 8 "row" pools were prepared by extracting DNA from high-density filters cut into vertical or horizontal strips. The DNA extraction protocol and PCR amplification protocol were as described (14) .
YAC End Isolation. The vectorette-PCR method was used as described (16) to isolate insert DNA at the YAC ends. To increase the length of specific-sequence DNA, several enzymes were tested sequentially to generate restriction fragments for PCR amplification. Vectorette linkers were constructed by hybridizing pairs of the following primers: YVJ, 5'-ANTCAAGGAGAGGACGCTGTCTGTCGAAGGT-AAGGAACGGACGAGAGAAGGGAGAG-3'; YV2, 5'-CT-CTCCCTTCTCGAATCGTAACCGTTCGT/ACGAGA-ATCGCTGTCCTCTCCTTG-3'; YV3, 5 GACAGAGGCG and GGTGATGGATCAGTCTCTCCA;  Y4T, ATCACGCCTACACATCCTCTG and CTCTTCAT-AGTTGTTCACAGATAC; Y107U, CACAGCACATC-CCCTTGAGC and TGCTCAAATTATGGTTTTGAAA;  Y51U, CTCCCTTCTGTGAGGGTTCTAATAT and TGCT-CAAATTATGGGTTTGAAATAT; Y4U, GATTCTGTG-GTTAAAGATGT and GTAATCAAGTTGCTTATTCTTG;  Y34T, GTTTTTGTTTGCCTGGGAAA and AATACTG-TATTCAGCAAAGTTATCC; Y32T, TACACAATCTCT-TCCAGAAAACA and CATTGTGGGGTTTGATTTCC;  Y30T, TGCGCAGTTCACGTCTATGT and TTCTTAAGT-TCATGAATTGGTGG; Y23U, TCAGCATCCTAATCA-CAACCAC and GGGTAATGGAAAAAGGTTGGA; Y30U,  TATGCTGTGTTATGGACAATGC and GTAATGTTC-CTCCATGTAGTCATC; Y32U, TTAAACAGCAGAAGT-TGCCT and CCCTTCTTGAAGCTGTTAAA. RESULTS Library Screening. With the exception of YAC 4 (11), all YAC clones were isolated from the Centre d'Etude du Polymorphisme YAC library (13) , which was prepared by partial EcoRI digestion of total human DNA ligated into the vector pYAC4. Homologous YAC clones were identified by conventional hybridization techniques (18) or, in most cases, by two rounds of PCR screening of YAC DNA pools (14, 15) . With this approach, PCR amplification of 71 DNA pools was usually sufficient to identify a unique YAC address. On average, four YAC clones were identified by each STS sequence. "Positive" YACs were picked from glycerol stocks, colonies were amplified, and YAC DNA was purified in agarose blocks (20) . YAC DNA was separated from yeast chromosomal DNA by pulsed-field gel electrophoresis using a Pharmacia LKB apparatus with a hexagonal electrode array, and Southern blot filters were prepared. The filters were hybridized with radiolabeled human genomic DNA to give the number and size of the artificial chromosomes contained within each YAC colony (Table 1) . Aqueous genomic YAC DNA was also prepared (14) , and positive clones were verified by PCR amplification with the starting probe.
YAC-End Fragment Characterization. YAC ends were isolated by the vectorette-PCR method (16) Fig. 1 , the uracil end of YAC 107 (Y107U) maps to the chromosome 5 deleted region, whereas the tryptophan end maps outside the deletion, indicative of a chimeric YAC clone as designated in Table 1 . Table 1 shows 10 YACs with one end outside the deletion and 7 YACs with both ends mapping to the deletion. By this criterion, 53% of YAC clones (excluding YAC 4 from the Imperial Cancer Research Fund library) are chimeric. Several YACs (Y66, Y23, Y32, Y88) were further evaluated by in situ hybridization to metaphase chromosome spreads (19) . In each case, in situ hybridization verified the PCR mapping results (data not shown).
The vectorette-PCR method yielded YAC-end STS sequences in all but one case where it was attempted. PCR primers for a number of YAC ends were not generated when they were not crucial for development or verification of the contig. We were unable to amplify specific-sequence DNA for the uracil end of YAC 88 because of the presence of Alu-repeat sequences across the region. In addition, two YAC ends (YlllU and Y112T) recognized homologous sequences elsewhere on chromosome 5, as shown by their amplification of both whole chromosome 5 and chromosome 5 deletion (5q11.2-13.3) cell hybrid DNA (Fig. 1) . By definition, these YAC ends are not STS sequences. Other probes isolated from the region spanned by YAC 98 provide further evidence for chromosome 5 specific-repeat sequence DNA.
Several primer pairs spanning microsatellite repeat sequences from this region detected two independent polymorphic systems. In one case (9847), the upper polymorphic system segregated with JK348 and MAPIB, whereas the lower system mapped further down the long arm, outside the deletion region (data not shown). This phenomenon appears to be localized to the region spanned by CMSI to Y112T (Fig.  2) . The occurrence of low-copy-repeat element DNA in the region of the SMA-encoding gene could complicate subsequent high-resolution physical and genetic mapping.
Construction and Characterization of the YAC Contig. Because no STS sequences were known to map between the SMA-flanking markers JK348 and MAP1B, bilateral "walks" were executed from both starting markers. Overlap between two YAC clones was established by identification of two or Although the overall size of each YAC is drawn to scale, the degree of overlap between YACs is based only upon STS content and, thus, does not represent actual size of the homologous region (23) . We estimate the minimum distance from JK348 to MAPIB as the sum of the sizes of the nonoverlapping, nonchimeric YACs Y4, Y98, Y55, and Y19, which is -'1.8 Mb. The minimum distance spanned by the entire contig is 3.2 Mb. Similar to previous studies (24) , one region along the contig shown in Fig. 2 Overlap was confirmed by radiolabeling and hybridizing probe Y98U to restriction-digested, Southern-blotted DNA from YACs 107, 98, 111, and 112. Multiple common restriction fragments unambiguously identify homologous DNA shared between these clones (data not shown). Other preliminary evidence indicates that the overlap between clones Y98 and Y107 is minimal. Only one inter-Alu PCR band is shared in common between the two YACs, and only 6 of 92 bacteriophage subclones from YAC 98 are homologous to YAC 107.
The YAC contig is anchored to genomic DNA by five previously mapped genetic markers [EF (D5S25) (26) , JK348 (D5S435) (10) MAPIB (two microsatellite loci) (11), segregates with the disease locus, whereas marker 9847 was not informative.
I and JK53 (DSS112) (9)], and two distinctive microsatellite markers (CMS1 and 9847) (Fig. 2) . JK348 maps 0.1-2.2 centimorgans from MAPIB and EF (D5S125) maps centromeric to JK348 (10) . MAPIB and JK53 are separated by <150 kbp (11) .
Genetic Linkage Analysis. Microsatellite markers CMS1 and 9847 were developed directly from YAC 98 DNA. When genotyped against two families that reveal a recombination between JK348 and SMA, marker CMS1 segregates with the disease locus in both (Fig. 3) . Likewise, marker 9847 segregates with the SMA locus in one recombinant family, whereas JK348 recombines. Recombination between these additional physically mapped microsatellite markers and JK348 in the "recombinant" SMA families is important because it solidifies the evidence that SMA does, indeed, map to the genetically and physically mapped interval between JK348 and MAPIB. The alternative explanation, that these families with two affected children are unlinked families (i.e., misdiagnosed as cases of SMA or examples of nonallelic heterogeneity), becomes significantly less likely, given verification of the predicted recombination events in so small a region. Neither marker crosses the recombination breakpoints between MAPIB and SMA (data not shown).
DISCUSSION
The SMA-encoding gene has been localized to seven overlapping YAC clones between flanking markers JK348 and MAPIB. Thirty STS sequences together with seven genetic markers were used to determine overlap between YAC clones, identify chimeric YAC ends, and localize one region of genqmic instability. Fifty-three percent of the YACs characterized contained noncontiguous segments of genomic DNA. Furthermore, an unknown proportion of YAC clones might contain small deletions, undetectable by STS-typing or pulse-field gel mapping. A very powerful strategy for gene mappers, therefore, is to use the YAC-contig information (both DNA sequence and regions of overlap) to identify and order overlapping phage or cosmid clones. Small-insert clones are more efficient than YAC clones for the identification of homologous cDNA clones (17, 22) , for use as hybridization probes to detect chromosomal rearrangements that might define a disease gene, and for rapid development of genetic markers. Furthermore, small clone contigs provide a much more sensitive measure of the continuity of a YAC contig compared with alternative methods. Cell-sorted, chromosome-specific cosmid libraries are available as ordered arrays (Lawrence Livermore National Laboratories, Berkeley, CA) for many chromosomes. These libraries can be spotted as high-density filters (Biomek 1000 Workstation) and systematically screened with radiolabeled YAC DNA or inter-Alu PCR product (25) . This strategy circumvents the problem of YAC chimerism. Alternatively, YAC DNA clones can be subcloned as cosmid or bacteriophage, and these clones are arranged according to overlap. Again, if overlapping YAC clones are sufficiently "deep," crosshybridization of positive cosmid/phage clones with overlapping YACs can be used to avoid problems with high rates of chimerism. Importantly, the regions of YAC overlap provide a powerful means to physically order subclones, or homologous clones, from the region. In a preliminary set of experiments, we have subcloned the DNA from YACs 55, 88, 97, 98, and 107 into bacteriophage and begun to assemble the sublibraries as overlapping clones assigned to each region of YAC overlap. In addition, several hundred chromosome 5 cosmid clones have been identified by screening high-density filters. Microsatellite markers that are physically mapped to each interval of YAC overlap spanning the disease gene interval need to be developed. These markers should provide a powerful resource for the assessment of linkage disequilibrium to the disease locus. In summary, the elaborate YACclone scaffolding provides an extremely useful resource to complete the isolation and identification of the SMAencoding gene.
